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Abstract
Background: Dietary 1(3)-behenoyl-2,3(1)-dioleoyl-rac-glycerol (BOO) has been reported to inhibit pancreatic lipase
activity in vitro and suppress postprandial hypertriacylglycerolemia in humans. In the present study, the anti-obesity
activities of BOO and its inhibitory effects on lymphatic triacylglycerol (TAG) absorption were investigated in rats.
Methods: In Experiment 1, rats were fed either BOO or soybean oil (SO) diet for 6 weeks. In the BOO diet, 20% of
SO was replaced with an experimental oil rich in BOO. In Experiments 2 and 3, rats cannulated in the thoracic duct
were administered an emulsions containing trioleoylglycerol (OOO) or an oil mixture (OOO:BOO, 9:1). Tri[1-
14C]
oleoylglycerol (
14C-OOO) was added to the emulsions administered in Experiment 3.
Results: No observable differences were detected in food intake or body weight gain between the BOO and SO
groups in Experiment 1. Plasma and liver TAG concentrations and visceral fat weights were significantly lower in
the BOO group than in the SO group. The apparent absorption rate of fat was significantly lower in the BOO
group than in the SO group. In Experiment 2, the lymphatic recovery of oleic and behenic acids was significantly
lower at 5 and 6 h after BOO administration than after OOO administration. In Experiment 3, the lymphatic
recovery of
14C-OOO was significantly lower at 5 and 6 h after BOO administration than after OOO administration.
Conclusions: These results suggest that BOO prevents deposition of visceral fat and hepatic TAG by lowering and
delaying intestinal absorption of TAG.
Background
Behenic acid is a long-chain saturated fatty acid consist-
ing of 22 carbon atoms. The physiological functions of
structured triacylglycerols (TAGs) containing behenic
and medium-chain fatty acids have been examined in
previous studies [1-3]. In these studies, structured TAGs
were shown to reduce fat absorption in rats. This reduc-
tion has been attributed to the low absorbability of
behenic acid. Therefore, behenic acid can be utilized as
a functional component of low-calorie fats. Dietary fats
containing behenic acid are expected to reduce visceral
fat deposition. However, only few studies have examined
the effects of TAG containing behenic acid on visceral
fat deposition.
1(3)-Behenoyl-2,3(1)-dioleoyl-rac-glycerol (BOO) is a
structured TAG with behenic acid at the 1 or 3 position.
In our previous study, analysis of structured TAGs that
are resistant to hydrolysis by pancreatic lipase revealed
that BOO has an inhibitory effect on this hydrolysis [4].
In addition, Arishima et al. demonstrated that when
10% of dietary fat is replaced with BOO, postprandial
serum TAG levels are suppressed in mildly hypertriacyl-
glycerolemic patients [5]. These observations suggest
that BOO suppresses intestinal absorption of dietary fat.
Several studies have suggested that improvement of
postprandial hypertriacylglycerolemia is responsible for
the reductions in body fat mass that have been observed
in rodents and humans [6-13]. It has also been shown
that 1,3-diacylglycerol, oolong tea polymerized polyphe-
nols and tea catechins suppress postprandial hypertria-
cylglycerolemia by delaying intestinal TAG absorption,
* Correspondence: kojima.makiko@so.fujioil.co.jp
1Food Science Research Institute, Fuji Oil Co., Ltd., 4-3 Kinunodai,
Tsukubamirai-shi, Ibaraki 300-2497, Japan
Kojima et al. Lipids in Health and Disease 2010, 9:77
http://www.lipidworld.com/content/9/1/77
© 2010 Kojima et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.in addition to reducing visceral fat deposition [6-9,11].
Therefore, it is believed that BOO has the ability to
interfere in fat absorption and prevent visceral fat
deposition. In this study, the effects of BOO on visceral
fat deposition in rats and fat absorption in lymph-can-
nulated rats were examined.
Materials and methods
Materials
Behenic acid ethyl ester was prepared by heating behe-
nic acid (95% purity; Tokyo Chemical Industry, Tokyo,
Japan) that had been solubilized in ethanol containing
sulfuric acid (98% purity; Kishida Chemical, Osaka,
Japan) as a catalyst. A BOO-rich experimental oil was
synthesized by enzymatic interesterification of sunflower
oil containing 80% oleic acid (Fuji Oil Co., Osaka,
Japan) and behenic acid ethyl ester using 1,3-specific
lipase from Rhizopus niveus. After elimination of fatty
acid ethyl esters by distillation, the residual oil was
mixed with n-hexane. Then, the oil/solvent mixture was
cooled and crystallized at -5°C. The BOO-rich experi-
mental oil was obtained by filtration followed by eva-
poration of n-hexane. The percentage of BOO was
41.8% in the experimental oil, which was added to the
feed used in Experiment 1. The composition of fatty
acids in the experimental oil rich in BOO was as fol-
lows: 16:0, 2.6%; 18:0, 3.9%; 18:1n-9, 56.3%; 18:2n-6,
2.9%; 20:0, 3.0% and 22:0, 30.9%. The molecular species
of TAG constituting the oil are shown in Table 1, and
were analyzed by high performance liquid chromatogra-
phy (HPLC) (Shimadzu, Kyoto, Japan) using the LiChro-
sorb RP-18-5 column (5-μm particle, 4.6 mm × 250
mm; GL Sciences, Tokyo, Japan); acetone/acetonitrile
solvent, 80/20 (v/v); 2% (v/v) acetone solution concen-
tration; 0.9 ml/min carrier velocity; 20°C and a refractive
index detector (Shimadzu). Purified BOO was obtained
from the experimental oil by preparative HPLC (Waters,
Milford, MA, USA) using the SunFire C18 column
(5-μm particle, 50 mm × 250 mm; Waters); acetone/
acetonitrile solvent, 80/20 (v/v); 10% (v/v) acetone solu-
tion concentration; 1.1 ml/min carrier velocity; 20°C and
a refractive index detector (Waters).
Effect of dietary BOO on visceral fat deposition in rats
fed a high-fat diet (Experiment 1)
Six-week-old male Wistar rats were purchased from
J a p a nS L C ,I n c .( S h i z u o k a ,J a p a n ) .T h ea n i m a l sw e r e
individually housed under controlled room temperature
(23°C ± 1°C), humidity (55% ± 5%) and light-dark-cycle
(light from 0700-1900 h). All rats were allowed free
access to a commercial chow (CRF-1; Oriental Yeast,
Tokyo, Japan) for 4 days. They were divided into
2 groups and fed the assigned experimental diet for
6 weeks. The composition of the experimental diets was
as follows (per 100 g diet): 20.0 g casein; 0.3 g L-cystine;
10.0 g sucrose; 18.75 g b-cornstarch; 13.2 g a-corn-
starch; 3.5 g AIN-93G mineral mixture (Oriental Yeast);
1.0 g AIN-93 vitamin mixture (Oriental Yeast); 5.0 g
cellulose; 0.25 g choline bitartrate and 0.0014 g tert-
butylhydroquinone. The dietary fat consisted of soybean
oil (SO) in the SO group, which was added at a concen-
tration of 28 g per 100 g diet. In the BOO group, 20%
of SO was replaced with the BOO-rich experimental oil.
As a result, the percentages of BOO and behenic acid
in the experimental diets were 2.3% and 1.7%,
respectively.
At the end of the feeding period, the rats were fasted
for 18 h (1800-1000), following which blood was with-
drawn from the abdominal aorta using a heparinized
syringe under isoflurane anesthesia. Liver and abdominal
adipose tissue samples from epididymal, perirenal and
mesenteric sites were carefully removed and weighed.
Plasma was separated by centrifugation at 1,900 g for
15 min at 4°C and frozen at -80°C until analyzed.
Feces were collected for 3 days before the end of
the feeding period and dried. The total fat content of
the feces was calculated by weighing the feces before
and after fat extraction using a solvent mixture of
petroleum ether and acetic acid (100:1). Plasma TAG
and total cholesterol concentrations and aspartate
aminotransferase (AST) and alanine aminotransferase
(ALT) activities were enzymatically measured using
Dry Chem 7000V (FUJIFILM Medical, Tokyo, Japan).
Liver lipids were extracted using the procedure
described by Folch et al. [14]. TAG and total choles-
terol concentrations were measured using previously
described methods [15].
Table 1 Molecular TAG species in the experimental oil
used in Experiment 1
Ingredient (%) Species (%)
St-O-O 56.7
BOO 41.8
SOO 4.3
POO 1.7
AOO 3.6
BLiO 5.3
St-O-St 25.3
BOB 6.5
BOS 4.8
POS 4.3
BOP 3.8
OOO 9.4
DG 5.9
unknown 2.7
St: saturated fatty acid; O: oleic acid; B: behenic acid; A: arachidic acid;
S: stearic acid; P: palmitic acid; G: lignoceric acid; DG: diacylglycerol.
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[1-
14C]oleoylglycerol in thoracic duct-cannulated rats
(Experiments 2 and 3)
Eight-week-old male SD rats were obtained from CLEA
Japan (Tokyo, Japan). After a 4-day adaptation period, a
cannula was inserted into the left thoracic duct to collect
lymphatic fluid and a cannula was inserted into the sto-
mach, using previously described procedures [6]. After
surgery, a physiological solution containing 139 mM glu-
cose and 85 mM NaCl was continuously infused over-
night at a rate of 3.4 ml/h through the stomach cannula.
In Experiment 2, emulsions containing 200 mg trioleoyl-
glycerol (OOO group; Sigma, MO, USA) or an oil mix-
ture of OOO:BOO (9:1) (BOO group), 50 mg fatty acid-
free albumin (Wako Pure Chemical Industries, Osaka,
Japan) and 200 mg sodium taurocholate (Nacalai Tesque,
Kyoto, Japan) were prepared by ultrasonication. After
lymph was collected for 2 h (-2 to 0 h), the emulsion was
administered to the stomach and the infusion of the glu-
cose/NaCl solution was continued. Lymph was collected
at the following intervals after administration of the test
emulsions: 0-1, 1-2, 2-3, 3-4, 4-5, 5-6 and 6-8 h. The col-
lection tubes contained EDTA-2Na as an anticoagulant.
Lipids were extracted using a chloroform/methanol mix-
ture (2:1, v/v) according to the method described by
Folch et al. [14], and then transmethylated using a BF3-
methanol complex using the method described by Ikeda
et al. [16]. Fatty acid methyl esters were analyzed using a
SHIMADZU GC-2014 capillary gas-liquid chromatogra-
phy apparatus equipped with ULBON HR-SS-10 (GL
Sciences). Pentadecanoic acid (Alfa Aesar, MA, USA) was
used as the internal standard. The fatty acid recovery rate
was calculated by subtracting the amount of fatty acids
recovered from the lymph collected 2 h prior to the
administration of the test emulsion (-2 to 0 h) from the
amount of fatty acids recovered from the lymph collected
after administration of the test emulsion.
In Experiment 3, thoracic duct-cannulated rats
received intragastric administrations of 3 ml of a test
emulsion containing 1 μCi of tri[1-
14C]oleoylglycerol
(
14C-OOO) (PerkinElmer, MA, USA). The composition
of the emulsion was the same as that used in Experi-
ment 2, except for the addition of radiolabelled TAG.
After administration, lymph was collected for 24 h and
radioactivity was measured using a liquid scintillation
counter. The maintenance of the experimental rats and
all other procedures were identical to those used in
Experiment 2.
All rat studies were carried out under procedures con-
sistent with the guidelines for conducting animal experi-
ments prepared by the Graduate School of Agricultural
S c i e n c ea tT o h o k uU n i v e r s i t ya n dt h eJ a p a n e s eS o c i e t y
for Nutrition and Food Science (Law no. 105 and Notifi-
cation no. 6 of the Japanese government).
Statistical analysis
All values are expressed as mean ± SE. Statistical ana-
lyses of data was performed using Student’s t-test. Dif-
ferences were considered significant at P < 0.05 (SPSS
Inc., Tokyo, Japan).
Results
Effect of dietary BOO on visceral fat deposition in rats
fed a high-fat diet (Experiment 1)
No significant differences were observed in food intake
or body weight gain between the SO and BOO groups
(Table 2). The relative weights of epididymal and
mesenteric adipose tissues and liver were significantly
lower in the BOO group than in the SO group. Plasma
TAG and total cholesterol concentrations were signifi-
cantly lower in the BOO group than in the SO group
(Table 2). Hepatic TAG and cholesterol concentrations
were also significantly lower in the BOO group than in
the SO group. No significant difference was observed in
the concentration of liver phospholipids (data not
shown). The activities of plasma AST and ALT were not
significantly different between the SO and BOO groups
(data not shown). Fecal weight was significantly higher
in rats fed the BOO diet than in those fed the SO diet
(Table 3). Diarrhea was not observed in either group.
Fecal excretion of fatty acids was significantly higher in
rats fed the BOO diet than in those fed the SO diet.
Both behenic acid and fatty acids other than behenic
acid were higher in the BOO group than in the SO
group. The apparent absorption rate of fat was signifi-
cantly lower in rats fed the BOO diet than in those fed
the SO diet.
Table 2 Body weights, food intakes, visceral fat weights
and concentrations of lipid parameters in plasma and
liver
SO BOO
Initial body weight (g) 160 ± 1 160 ± 1
Final body weight (g) 316 ± 4 309 ± 4
Body weight gain (g/day) 3.7 ± 0.1 3.6 ± 0.1
Food intake (g/day) 12.9 ± 0.2 13.0 ± 0.2
Liver (g/100 g body weight) 2.60 ± 0.02 2.52 ± 0.03*
Adipose tissue weight (g/100 g body weight)
Epididymal 2.84 ± 0.10 2.49 ± 0.09*
Perirenal 2.75 ± 0.11 2.52 ± 0.12
Mesenteric 1.84 ± 0.06 1.62 ± 0.08*
Total 7.43 ± 0.27 6.62 ± 0.27*
Plasma Triacylglycerol (mg/dl) 82.5 ± 7.1 65.1 ± 3.8*
Total cholesterol (mg/dl) 49.3 ± 2.4 42.6 ± 1.9*
Liver Triacylglycerol (mg/g Liver) 28.7 ± 3.1 20.9 ± 1.8*
Total cholesterol (mg/g Liver) 5.26 ± 0.19 4.44 ± 0.15*
Values are mean ± SE, n = 14.
* indicates significant differences in corresponding values in rats fed the SO
diet (P < 0.05).
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Page 3 of 6Effect of BOO on lymphatic recovery of fatty acids in
thoracic duct-cannulated rats (Experiment 2)
No significant differences were observed in the lympha-
tic flow rates between the OOO and BOO groups (data
not shown). The lymphatic recovery rates of oleic and
behenic acids are shown in Figure 1A. The lymphatic
recovery rates were significantly lower in the BOO
group than in the OOO group at 5 and 6 h after admin-
istration. The same tendency was observed at 1, 2, 3 and
4 h after administration. The lymphatic recovery rate of
oleic acid in the BOO group was also significantly lower
compared to that in the OOO group at 5 and 6 h after
administration (Figure 1B). The lymphatic recovery rate
of the BOO group for behenic acid was significantly
lower than that of the OOO group for oleic acid at all
time points and in the BOO group at 6 h after adminis-
tration (Figure 1B).
Effect of BOO on lymphatic recovery of
14C-OOO in
thoracic duct-cannulated rats (Experiment 3)
No significant differences were observed in the periodic
and total lymphatic flow rates between the OOO and
BOO groups (data not shown). As shown in Figure 2,
the lymphatic recovery of
14C-OOO was significantly
lower in the BOO group than in the OOO group at 5
and 6 h after administration.
Discussion
In this study, BOO-induced reduction of visceral fat
deposition was demonstrated for the first time (Table
2). Significant reductions in plasma and hepatic TAG
concentrations were also observed in the BOO group
(Table 2). Fecal excretions of fatty acids, behenic acid
and fatty acids other than behenic acid were higher in
the BOO group than in the SO group (Table 3). These
results suggest that a reduction in fat absorption by
dietary BOO causes decreases in plasma and hepatic
TAG levels and visceral fat deposition. In the experi-
ment on lymph-cannulated rats, the administration of
BOO and OOO reduced the lymphatic recovery rate
of oleic acid (Figure 1A). The lymphatic recovery rate of
behenic acid was also lower than that of oleic acid (Fig-
ure 1B). It was also demonstrated that BOO reduces the
lymphatic recovery rate of
14C-OOO (Figure 2). These
results suggest that the digestion and absorption of
BOO and OOO were suppressed in the BOO group.
Arishima et al. [4] reported in an in vitro study that
Table 3 Fecal weights and fat excretions in feces
SO BOO
Fecal weight (g/day) 0.99 ± 0.02 1.23 ± 0.03*
Fecal fatty acids (mg/day) 88.2 ± 4.7 278 ± 12*
behenic acid (mg/day) 5.96 ± 0.18 125 ± 4*
fatty acids other than behenic acid
(mg/day)
82.2 ± 4.6 152 ± 9*
Apparent absorption of fat (%) 97.5 ± 0.1 92.1 ± 0.2*
Values are mean ± SE, n = 14.
* indicates significant differences in corresponding values in rats fed the SO
diet (P < 0.05).
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Figure 1 Effect of BOO on lymphatic recovery of oleic and behenic acids (A) and each fatty acid (B) in rats receiving intragastric
administration of fat emulsions. Values are mean ± SE; n = 5 (OOO group), 7 (BOO group). (A) * indicates significant differences in
corresponding values in rats that were administered the BOO emulsion (P < 0.05). (B) * indicates significant differences in corresponding values
of behenic acid absorption in the BOO group (P < 0.05). # indicates significant differences in corresponding values of oleic acid absorption in
the OOO group (P < 0.05).
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Page 4 of 6compared with the administration of only OOO, the
administration of an oil mixture of OOO:BOO (9:1)
suppresses the hydrolysis of BOO and OOO by pancrea-
tic lipase. This observation suggests that the reduction
of TAG absorption is induced by the inhibition of pan-
creatic lipase in the intestinal lumen. In studies on the
absorption of structured TAGs containing behenic and
medium-chain fatty acids, low absorbability was ascribed
only to behenic acid [1-3]. The present and previous
studies [4] have indicated the strong possibility that
BOO decreases fat absorption by suppressing the hydro-
lysis of BOO itself and by inhibiting the hydrolysis of
TAGs other than BOO.
Yoshida et al. reported that the apparent absorption of
TAG was 39% in rats fed a diet of 2% corn oil and 18%
behenic/caproic/caproic TAGs (B66) for 1 week, which
was lower than the apparent absorption of TAG in rats
fed SO exclusively [1]. The apparent absorption of behe-
nic acid was only 8% [1]. Webb et al. showed that when
caprenin containing caprylic, capric and behenic acids
was fed to rats, behenic acid absorption was 19% [3].
Based on these observations, they concluded that
behenic acid has low bioavailability and its poor absorb-
ability causes reductions in body weight and visceral fat
deposition. In the present study, the intake of BOO sig-
nificantly reduced apparent fat absorption compared
w i t ht h ei n t a k eo fS O( T a b l e3 ) .H o w e v e r ,c o m p a r e d
with the results of previous studies, apparent fat absorp-
tion was higher in this study and behenic acid absorp-
tion was also obviously higher when rats were fed BOO.
This may be due to differences in the behenic acid con-
tent of the dietary fats used. In this study, the behenic
acid content was 1.7% of the experimental diet, whereas
in previous studies, the behenic acid content was 6.8%
[1] and 6.1% [3]. It has been previously reported that
the lymphatic absorption rate of stearic acid, a fatty acid
with a high melting point, when administered as a mix-
ture of oils from completely hydrogenated tallow and
soybean oil in various proportions, was inversely propor-
tional to the stearic acid content of the mixed oils [17].
In this study, although the behenic acid content of the
administered diets was relatively lower than that used in
previous studies, visceral fat amounts were shown to
clearly decrease in the BOO group. These results sug-
gest that BOO has the potential to exert an inhibitory
effect on fat absorption at relatively low doses. Further
studies are necessary to determine the effective dose in
humans.
Arishima et al. reported that dietary BOO suppresses
postprandial hypertriacylglycerolemia in mildly hyper-
triacylglycerolemic patients when 10% of dietary fat is
replaced with BOO [5]. The present study suggests that
this suppression is caused by lower absorption of dietary
fat and BOO via the inhibition of pancreatic lipase.
Since postprandial hypertriacylglycerolemia is thought to
be a risk factor for coronary heart disease [18-20], it is
possible that BOO has other beneficial effects on the
prevention of coronary heart disease, in addition to pre-
venting obesity and dyslipidemia.
The present study demonstrates the possibility that
BOO can be utilized as a fat substitute that does not
result in an increase in calorie assimilation. BOO might
also have some beneficial effects on the prevention of
obesity and atherosclerosis through the suppression of
postprandial hypertriacylglycerolemia. The melting point
of BOO is 31°C, and its use as a supplement to vegeta-
ble oil in relatively low amounts would be convenient
for use in cooking oils. Dietary BOO did not influence
plasma AST and ALT activities in these feeding studies.
Therefore, vegetable oils containing BOO can be used
as safe and functional cooking oils.
Conclusions
The present study demonstrated that BOO reduces visc-
eral fat deposition and plasma and hepatic TAG levels
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Figure 2 Effect of BOO on lymphatic recovery of
14C-OOO in
rats receiving intragastric administration of fat emulsions.
Values are mean ± SE; n = 5 (OOO group), 6 (BOO group). *
indicates significant differences in corresponding values of
14C-OOO
absorption in rats that were administered the BOO emulsion
(P < 0.05).
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Page 5 of 6in rats. These observations suggest that these reductions
are caused by lowering and delaying intestinal absorp-
tion of TAG. BOO can be effective for the prevention of
obesity and coronary heart disease.
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